November 30, 2016 - By Nellie Frank
In a research note shared with investors and clients on Wednesday morning, Acal PLC (LON:ACL) stock “Add” was reconfirmed by Analysts at Numis. They currently have a GBX 260.00 PT on the stock. Numis’s PT would indicate a potential upside of 21.78% from the company’s previous close.
Out of 3 analysts covering Acal PLC (LON:ACL), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 339 is the highest target while GBX 260 is the lowest. The GBX 304.67 average target is 42.04% above today’s (GBX 214.5) stock price. Acal PLC has been the topic of 30 analyst reports since July 29, 2015 according to StockzIntelligence Inc. The stock of Acal plc (LON:ACL) has “Buy” rating given on Friday, February 12 by Peel Hunt. The stock of Acal plc (LON:ACL) has “Buy” rating given on Tuesday, November 29 by Peel Hunt. As per Friday, April 15, the company rating was maintained by Peel Hunt. On Wednesday, July 29 the stock rating was maintained by FinnCap with “Buy”. Peel Hunt downgraded Acal plc (LON:ACL) on Friday, November 27 to “Add” rating. FinnCap maintained Acal plc (LON:ACL) rating on Monday, January 11. FinnCap has “Buy” rating and GBX 339 price target. The stock of Acal plc (LON:ACL) earned “Add” rating by Peel Hunt on Friday, January 8. The rating was maintained by FinnCap with “Buy” on Wednesday, June 1. The firm has “Buy” rating given on Monday, November 30 by FinnCap. Peel Hunt maintained the stock with “Buy” rating in Friday, November 6 report.
About 90,995 shares traded hands or 57.12% up from the average. Acal plc (LON:ACL) has declined 19.77% since May 3, 2016 and is downtrending. It has underperformed by 25.00% the S&P500.
ACAL plc designs, manufactures and distributes electronic products and solutions. The company has a market cap of 136.81 million GBP. The Firm operates through two divisions: Custom Distribution and Design & Manufacturing. It has a 19.75 P/E ratio. The Custom Distribution segment provides customized electronic, photonic and medical products to the industrial, medical and healthcare markets, both from a range of international suppliers and from the Company’s Design & Manufacturing division.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Nellie Frank